IN THE SPOTLIGHT

Rate of Second Primary Lung Cancers With Lobar vs Sublobar Resection of T1aN0 NSCLC

Rate of Second Primary Lung Cancers With Lobar vs Sublobar Resection of T1aN0 NSCLC

Risks of Cardiovascular Disease in Patients Receiving Therapies for Lung Cancer

Risks of Cardiovascular Disease in Patients Receiving Therapies for Lung Cancer

Study suggests tumour microenvironments could predict cancer progression

Study suggests tumour microenvironments could predict cancer progression

Liquid biopsy: may ctDNA tumour fraction help interpret negative results?

Liquid biopsy: may ctDNA tumour fraction help interpret negative results?

Perioperative Tislelizumab Plus Chemotherapy in Resectable NSCLC

Perioperative Tislelizumab Plus Chemotherapy in Resectable NSCLC

NSCLC: Neoadjuvant Chemoimmunotherapy vs Neoadjuvant Chemotherapy

NSCLC: Neoadjuvant Chemoimmunotherapy vs Neoadjuvant Chemotherapy

Exposure to Agent Orange is associated with increased recurrence after surgical treatment of stage I non–small cell lung cancer

Exposure to Agent Orange is associated with increased recurrence after surgical treatment of stage I non–small cell lung cancer

Impact of travel distance on receipt of indicated adjuvant therapy in resected non–small cell lung cancer

Impact of travel distance on receipt of indicated adjuvant therapy in resected non–small cell lung cancer

Treating Women With Lung Cancer: Screening, Treatment, and Sexual and Reproductive Health

Treating Women With Lung Cancer: Screening, Treatment, and Sexual and Reproductive Health

Disparities in Lung Cancer Screening and Treatment Persist in Patients Age 80+

Disparities in Lung Cancer Screening and Treatment Persist in Patients Age 80+